IMMIX BIOPHARMA, INC. Earnings Per Share (Basic)
IMMIX BIOPHARMA, INC. (IMMX) reported Earnings Per Share (Basic) of -$0.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- IMMIX BIOPHARMA, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.18.
- IMMIX BIOPHARMA, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.18.
- IMMIX BIOPHARMA, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.26.
- IMMIX BIOPHARMA, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.24.
- IMMIX BIOPHARMA, INC. earnings per share, basic for fiscal 2025 was -$0.89.
- IMMIX BIOPHARMA, INC. earnings per share, basic for fiscal 2024 was -$0.76.
- IMMIX BIOPHARMA, INC. earnings per share, basic for fiscal 2023 was -$0.89.
- IMMIX BIOPHARMA, INC. earnings per share, basic for fiscal 2022 was -$0.59.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.18 10-Q · filed 2026-08-07 | -$0.36 10-Q · filed 2026-08-07 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2026-03-31 | -$0.18 10-Q · filed 2026-05-07 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.89 10-K/A · filed 2026-03-27 |
| 2025-09-30 | -$0.24 10-Q · filed 2025-11-07 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.61 10-Q · filed 2025-11-07 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-06-30 | -$0.22 10-Q · filed 2026-08-07 | -$0.37 10-Q · filed 2026-08-07 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-03-31 | -$0.15 10-Q · filed 2026-05-07 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2024-12-31 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$0.76 10-K/A · filed 2026-03-27 |
| 2024-09-30 | -$0.24 10-Q · filed 2025-11-07 | -$0.40 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$0.60 10-Q · filed 2025-11-07 | -$0.85 derived: net income ÷ weighted average shares · filed 2025-11-07 |
| 2024-06-30 | -$0.15 10-Q · filed 2025-08-08 | -$0.36 10-Q · filed 2025-08-08 | -$0.60 derived: net income ÷ weighted average shares · filed 2025-08-08 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-08-08 |
| 2024-03-31 | -$0.22 10-Q · filed 2025-05-08 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$0.69 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-05-08 |
| 2023-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$0.70 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$0.89 10-K · filed 2025-03-25 |
| 2023-09-30 | -$0.23 10-Q · filed 2024-11-12 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.65 10-Q · filed 2024-11-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.24 10-Q · filed 2024-08-12 | -$0.42 10-Q · filed 2024-08-12 | -$0.69 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-08-12 |
| 2023-03-31 | -$0.18 10-Q · filed 2024-05-09 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$0.56 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$0.67 derived: net income ÷ weighted average shares · filed 2024-05-09 |
| 2022-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.50 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.59 10-K · filed 2024-03-29 |
| 2022-09-30 | -$0.11 10-Q · filed 2023-11-13 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.32 10-Q · filed 2023-11-13 | -$2.35 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.11 10-Q · filed 2023-08-11 | -$0.21 10-Q · filed 2023-08-11 | -$2.38 derived: net income ÷ weighted average shares · filed 2023-08-11 | -$2.92 derived: net income ÷ weighted average shares · filed 2023-08-11 |
| 2022-03-31 | -$0.10 10-Q · filed 2023-05-12 | -$2.62 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$3.37 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$3.93 derived: net income ÷ weighted average shares · filed 2023-05-12 |
| 2021-12-31 | -$4.98 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$5.83 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$6.20 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$6.64 10-K · filed 2023-03-27 |
| 2021-09-30 | -$0.12 10-Q · filed 2022-11-09 | -$0.18 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.48 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$0.06 10-Q · filed 2022-08-12 | -$0.36 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$0.30 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |